Skip to main content
. 2017 May 24;7:2360. doi: 10.1038/s41598-017-02546-x

Figure 3.

Figure 3

Effect of colonic administration of SCFA mixtures on fasting and postprandial plasma glucose (A), insulin (B) and free glycerol (C,D) concentrations (A) Fasting (t0–t120 min) and postprandial (t180–t300 min) plasma glucose concentrations after colonic SCFA infusions. (B) Fasting (t0–t120 min) and postprandial (t180–t300 min) plasma insulin concentrations after colonic SCFA infusions. (C) Fasting (t0–t120 min) and postprandial (t180–t300 min) plasma free glycerol concentrations after colonic SCFA infusions. (D) iAUC for fasting (t0–t120 min) plasma free glycerol following colonic SCFA infusion. Overall treatment effect for free glycerol P = 0.030 (period P = 0.483, carry-over P = 0.832). Values are means ± SEMs (n = 12). Statistical significance indicated as asterisk (*) when **P < 0.01, *P < 0.05.